Scott M. Rocklage has been serving as the managing partner of 5AM Ventures since 2004. He schooled at the University of California where he got his B.S in Chemistry, and he did his Ph.D. in Chemistry at MIT. Scott did his research in Richard R. Schrocks’ laboratory. He has over 30 years of experience in healthcare management and also in strategic leadership that he made FDA approve three drugs in the U.S. In the past, worked with Cubist Pharmaceuticals as their CEO and also served Nycomed Salutar as the CEO and President. He has over 100 pre-reviewed publications and has invented over 30 patents in U.S.
Scott Rocklage joined three investors in 5AM Ventures. The company was founded in 2002 and was then known as Spin-out of Bay City Capital. In their first year of establishment, the founders invested in six biotechnology companies. Scott has steered the company’s growth by; building infrastructure where a drug can be launched, seen through the approval of three drugs, and also developed strong pipelines since joining the team.
5AM Ventures is a company whose main focus is to invest in businesses that are just starting so as to build biotechnology companies. Their primary mission is to build life science companies for the next generation that can give back the best returns to their investors. They help other healthcare companies that try to solve health care needs by developing new medicines so as to be able to treat, diagnose, and prevent a wide range of diseases.
The firm does a lot of research in the medical field where their professionals are able to handle operational, medical, finance, and legal entities. They work with portfolio companies where their experts assume other companies roles in operations, managing recruitment, developing businesses, fundraising, and setting corporate strategies.
Dr. Rocklage’s leadership has helped companies that are subjected to 5AM to be at the forefront in treating a wide variety of diseases. The growth of 5AM can be credited his approach to solving scientific equation in finding the right companies to work with and also searching for investment opportunities for the company. His rich background in healthcare, strategic leadership, and science has made him be the best leader in the healthcare world.